Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hassan Almoustafa"'
Autor:
Abul Kalam Azad, Wan Mohd Azizi Wan Sulaiman, Hassan Almoustafa, Mohamad Dayoob, Vinoth Kumarasamy, Vetriselvan Subramaniyan, Jamilah M. Alshehri, Azmat Ali Khan
Publikováno v:
Data in Brief, Vol 53, Iss , Pp 110202- (2024)
5-Fluorouracil (5-FU) has been the primary drug used in chemotherapy for colorectal carcinoma, and localizing the drug would be effective in avoiding its side effects and improving therapeutic outcomes. One approach to achieve this is by encapsulatin
Externí odkaz:
https://doaj.org/article/938c7034587248d9b9a4471bea85b40e
Autor:
Abul Kalam Azad, Joanne Lai, Wan Mohd Azizi Wan Sulaiman, Hassan Almoustafa, Salah Abdalrazak Alshehade, Vinoth Kumarasamy, Vetriselvan Subramaniyan
Publikováno v:
Pharmaceutics, Vol 16, Iss 2, p 160 (2024)
Turmeric contains curcumin, a naturally occurring compound with noted anti-inflammatory and antioxidant properties that may help fight cancer. Curcumin is readily available, nontoxic, and inexpensive. At high doses, it has minimal side effects, sugge
Externí odkaz:
https://doaj.org/article/69edbc63abf94cbc9c92f0147b4e4c78
Autor:
Salah Abdalrazak Alshehade, Raghdaa Hamdan Al Zarzour, Michael Mathai, Nelli Giribabu, Atefehalsadat Seyedan, Gurjeet Kaur, Fouad Saleih Resq Al-Suede, Amin Malik Shah Abdul Majid, Vikneswaran Murugaiyah, Hassan Almoustafa, Mohammed Abdullah Alshawsh
Publikováno v:
Pharmaceuticals, Vol 16, Iss 1, p 109 (2023)
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of liver disease. Orthosiphon aristatus (Blume) Miq, a traditional plant in South Asia, has previously been shown to attenuate obesity and hyperglycaemic conditions. Eight weeks of
Externí odkaz:
https://doaj.org/article/d4caa0ab56b84251981e8340954023b4
Autor:
Salah Alshehade, Mohammed Abdullah Alshawsh, Vikneswaran Murugaiyah, Muhammad Asif, Omayma Alshehade, Hassan Almoustafa, Raghdaa Hamdan Al Zarzour
Publikováno v:
Life Sciences. 305:120732
Metabolic dysfunction-associated fatty liver disease (MAFLD), proposed in 2020 is a novel term for non-alcoholic fatty liver disease (NAFLD) which was coined for the first time in 1980. It is a leading cause of the most chronic liver disease and hepa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62edf8ca5789d9338c5fe512120d6066
https://doi.org/10.1016/j.lfs.2022.120732
https://doi.org/10.1016/j.lfs.2022.120732